Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NanoPass Technologies
Ness Ziona, Israelnanopass.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
NanoPass’s MicronJet™ is the first and only sub-millimeter (<1mm) microneedle to receive FDA clearance as an intradermal delivery device. It is supported by extensive clinical data and regulatory approvals in major markets. The company’s technology has been used in multiple phase I–III clinical studies, especially for vaccines, demonstrating virtually pain-free administration and improved patient experience compared to traditional needles.
- Therapeutic areas
- DermatologyInfectious Diseases
- Modalities
- DeviceNanoparticle (via microneedle platform for intradermal delivery; not a therapeutic but a modality of administration)
- Industry
- Consumable Medical Devices
02
Partnerships
West Pharmaceutical ServicesInfectious Diseases Research Institute, Seattle (global health vaccines including tuberculosis and pandemic flu)Additional partners in EU, China, South Korea, etc.
Beyond the preview
Go deeper on NanoPass Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NanoPass Technologies.